GlassScriptPhysician profile
Sherien George
NPI 1376002535
$3,186.21
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,151 · 2022: $35.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.09 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $385.41 | 2021 | |
| Sunovion Pharmaceuticals INC. | $310.15 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $307.43 | 2021 | |
| Ironshore Pharmaceuticals INC. | $260.42 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $191.19 | 2021 | |
| Alkermes, INC. | $184.39 | 2021 | |
| Bausch Health US, LLC | $175.83 | 2021 | |
| Janssen Pharmaceuticals, INC | $148.35 | 2021 | |
| Neurocrine Biosciences, INC. | $147.22 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $121.36 | 2021 | |
| Vanda Pharmaceuticals INC. | $112.36 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $92.89 | 2021 | |
| Jazz Pharmaceuticals INC. | $76.69 | 2021 | |
| Adlon Therapeutics L.P. | $72.43 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $56.10 | 2021 | |
| Lundbeck LLC | $53.27 | 2021 | |
| Neos Therapeutics, LP | $37.27 | 2021 | |
| Supernus Pharmaceuticals, INC. | $21.04 | 2021 | |
| Indivior INC. | $14.06 | 2021 | |
| Merck Sharp & Dohme LLC | $13.26 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherien George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.